Abstract
Effects of N-methyl-D-aspartate (NMDA) and potassium on 5-day-old rat's brain were examined. We measured extracellular striatal monoamines such as dopamine (DA), 3,4 dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindole-3-acetic acid (5-HIAA) using intracerebral microdialysis. After 3 h stabilization, pups received varying concentrations of NMDA (1–3 mM) and potassium (200–800 mM) by intrastriatal perfusion for 32 minutes. Increasing the concentration of NMDA and potassium induced a dose related DA increase (p < 0.001), whereas DOPAC, HVA, and 5-HIAA decreased significantly. Five days later the same animals were sacrificed and the weight reduction of their cerebral hemispheres was measured. The weight of the drug perfused side was significantly reduced compared with that of the contralateral one. We examined next the relationship between the level of maximum DA and the relative hemisphere weight reduction. The DA peak was highly correlated with the hemisphere weight reduction (r = 0.70, n = 52, p < 0.001 in the NMDA group, r = 0.83, n = 30, p < 0.001 in the potassium group, respectively). These data show that each treatment alter striatal monoamine metabolism in immature rat brain and that the extracellular DA peak is a potential early indicator to estimate brain injury.
Similar content being viewed by others
REFERENCES
Busto, R., Harik, S. I., Yoshida, S., Scheinberg, P., and Ginsberg, M. D. 1995. Cerebral norepinephrine depletion enhances recovery after brain ischemia. Ann. Neurol. 18:329-336.
Globus, MY-T., Ginsberg, M. D., Harik, S. I., Busto, R., and Dietrich, W. D. 1987. Role of dopamine in ischemic striatal injury: metabolic evidence. Neurology. 37:1712-1719.
Gordon, K, Statman, D., Johnston, M. V., Robinson T. E., Becker, J. B., and Silverstein, F. 1990. Transient hypoxia alters striatal catecholamine metabolism in immature brain: An in vivo microdialysis study. J. Neurochem. 54:605-611.
Wurtman, R. J., Larin, F., and Lavyne, M. H. 1974. Reduction in brain dopamine following experimental cerebral ischemia. Nature. 247:283-284.
McDonald, J. W., Silverstein, F. S., and Johnston, M. V. 1988. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res. 459:200-203.
Ikonomidou, C., Mosinger, J. L., Shahid Salles, K., Labruyere, J., and Olney, J. W. 1989. Sensitivity of the developing rat brain to hypoxic/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J. Neurosci. 9:2809-2818.
McDonald, J. W., Johnston, M. V., and Young, A. 1990. Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus. Exp. Neurol. 110:237-247.
Brady, R., Smith, K., and Swann, J. 1991. Calcium modulation of the N-methyl-D-aspartate (NMDA) response and electrographic seizures in immature hippocampus. Neurosci. Lett. 124:92-96.
Badoer, E., Wurth, H., Turck, D., Qadri, F., Itoi, K., Dominiak, P., and Unger, T. 1989. The K+-induced increases in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:54-59.
Fairbrother, I., Arbuthnott, G., Kelly, J., and Butcher, S. 1990. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine. J. Neurochem. 54:1844-1851.
Fujikawa, D., Kim, I., Dantels, A., Alcaraz, and A., Sohn, T. 1996. In vivo elevation of extracellular potassium in the rat amygdala increases extracellular glutamate and aspartate and damages neurons. Neuroscience. 74:695-706.
Jing J., Aitken, P., and Somjen, G. 1991. Lasting neuron depression induced by high potassium and its prevention by low calcium and NMDA receptor blockade. Brain Res. 557:177-83.
McDonald, J. W., Roser, N. F., Silverstein, F. S., and Johnston, M. V. 1989. Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp. Neurol. 106:289-296.
Nakajima, W., Ishida, A., and Takada, G. 1996. Effect of anoxia on striatal monoamine metabolism in immature rat brain compared with that of hypoxia: an in vivo microdialysis study. Brain Res. 740:316-322.
Martinez-Fong, D., Rosales, M., Gongora-Alfaro, J., Hernandez, S., and Aceves, J. 1992. NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res. 595:309-315.
Ohta, K., Fukuchi, Y., Simazu, K., Komatsumoto, S., Ichijo, M., Araki, N., and Shibata, M. 1994. Presynaptic glutamate receptors facilitate release of norepinephrine and 5-hydroxytryptamine as well as dopamine in the neonatal and ischemic striatum. J. Autonom. Nerv. Syst. 49:S195-S202.
Westerink, B. H. C., Santiago, M., and De Vries, J. B. 1992. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:523-529.
Imperato, A., and Chiara, G. D. 1984. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci. 4:966-977.
Krebs, M. O., Desce, J. M., Kemel, M. L., Gauchy, C., Godeheu, G., Cheramy, A., and Glowinski, J. 1991. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:81-85.
Carter, C., Noel, F., and Scatton, B. 1987. Raised extracellular potassium relieves the blockade by magnesium of NMDA-induced cerebellar cyclic GMP production. Neurosci. Lett. 82:201-205.
Westerink, B. H. C., and Tuinte, M. 1986. Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid. J. Neurochem. 46:181-185.
Zetterstrom, T., Sharp, T., Collin, A., and Ungerstedt, U. 1988. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:327-334.
Holz, R., and Coyle, J. 1974. The effects of various salts, temperature, and alkaloids veratridine and batrachotoxin on the uptake of (3H) dopamine into synaptosomes from rat striatum. Mol. Pharmacol. 10:746-758.
Akiyama, Y., Ito, A., Koshimura, K., Ohue, T., Yamagata, S., Miwa, S., and Kikuchi, H. 1991. Effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum. Brain Res. 561:120-127.
Coyle, J. T., and Schwarcz, R. 1976. Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea. Nature. 263:244-246.
Koh, J. H., and Choi, D.W. 1987. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:83-90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakajima, W., Ishida, A., Ogasawara, M. et al. Effect of N-Methyl-D-Aspartate and Potassium on Striatal Monoamine Metabolism in Immature Rat: An In Vivo Microdialysis Study. Neurochem Res 23, 1159–1165 (1998). https://doi.org/10.1023/A:1020721900402
Issue Date:
DOI: https://doi.org/10.1023/A:1020721900402